Location History:
- Jouy-en-Josas, FR (2016)
- Paris, FR (2017)
Company Filing History:
Years Active: 2016-2017
Title: Inventor Marc-Antoine Perrin: A Pioneer in Medicinal Chemistry
Introduction
Marc-Antoine Perrin is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, evidenced by his impressive portfolio of patents. With a total of two patents to his name, Perrin’s work focuses on innovative processes and formulations that hold promise for the pharmaceutical industry.
Latest Patents
Perrin's latest patents include a highly specialized method for the preparation of crystal forms of the compound 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-methoxypyridine-2-carboxamide. This invention relates to various crystal forms designated as Crystal Forms A to I, which are essential in developing effective medicaments. Additionally, he has worked on polymorphic forms of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide, demonstrating his expertise in creating complex pharmaceutical compounds.
Career Highlights
Marc-Antoine Perrin has built a successful career at Sanofi, one of the largest pharmaceutical companies in the world. His innovative approaches in the laboratory have led to advancements in drug formulation and delivery mechanisms. Perrin’s ability to navigate the complexities of chemical processes has been invaluable to his company's research and development efforts.
Collaborations
Throughout his career, Perrin has collaborated with notable colleagues, including Pascal Billot and Didier Brige. These partnerships have enriched his research and contributed to the successful development of novel drug candidates. Working together, they have pushed the boundaries of medicinal chemistry, leading to promising therapeutic options.
Conclusion
Marc-Antoine Perrin stands out as a significant figure in the field of medicinal chemistry. His dedication to innovation and excellence is reflected in his patents and collaborative efforts. As he continues to work at Sanofi, the contributions of Perrin to pharmaceutical advancements are likely to grow, underscoring his impact on global health solutions.